Skip to contentSkip to navigation

All Genotypes HPV. HPV 16, HPV 18, Human papillomavirus


The human papillomavirus (HPV) is responsible for more than 80% of cervical cancer cases. There are about a hundred sub-types of HPV, 13 of which are designated as high risk. Of these, subtypes 16 and 18 alone are responsible for 70% of cervical cancers. The HPV test measures all high-risk subtypes and specifically indicates whether subtypes 16 and/or 18 are present.

The HPV screening test can be used alone or with a PAP test. It can also be used only if the PAP test reveals abnormalities (reflex testing). For women over age 30 (or sometimes 25), the HPV test can be used alone as a screening test. Before this age, the presence of the virus is very common and the vast majority of infections heal spontaneously. In younger women, the HPV test should only be done following a PAP test showing cellular abnormalities.

It should be noted that only a small percentage of high-risk chronic HPV infections will develop into cancer.

However, a positive HPV test, particularly for subtypes 16 and/or 18, is an indication for a colposcopy, even if the PAP test does not yet show any significant abnormality.

Biron sets itself apart

Liquid-based Pap test for HPV and uterine cancer screening*.

  • More sensitive than the conventional smear testing.
  • Results available in 5 to 7 business days, compared to 1 to 6 months for conventional smear testing.
  • Molecular detection of HPV from the same sample, if necessary.
  • Costs reimbursed by most insurers.

*A doctor's prescription is required.

Term of the Week

Predictive medicine

Medicine that links medical knowledge with data to predict a patient’s potential health problems. Examples include artificial intelligence and genetics.